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Abstract
Background: The transport of endoplasmic reticulum (ER)-derived COPII vesicles toward the ER-Golgi intermediate
compartment (ERGIC) requires cytoplasmic dynein and is dependent on microtubules. p150Glued, a subunit of dynactin, has
been implicated in the transport of COPII vesicles via its interaction with COPII coat components Sec23 and Sec24. However,
whether and how COPII vesicle tether, TRAPP (Transport protein particle), plays a role in the interaction between COPII
vesicles and microtubules is currently unknown.
Principle Findings:We address the functional relationship between COPII tether TRAPP and dynactin. Overexpressed TRAPP
subunits interfered with microtubule architecture by competing p150Glued away from the MTOC. TRAPP subunit TRAPPC9
bound directly to p150Glued via the same carboxyl terminal domain of p150Glued that binds Sec23 and Sec24. TRAPPC9 also
inhibited the interaction between p150Glued and Sec23/Sec24 both in vitro and in vivo, suggesting that TRAPPC9 serves to
uncouple p150Glued from the COPII coat, and to relay the vesicle-dynactin interaction at the target membrane.
Conclusions: These findings provide a new perspective on the function of TRAPP as an adaptor between the ERGIC
membrane and dynactin. By preserving the connection between dynactin and the tethered and/or fused vesicles, TRAPP
allows nascent ERGIC to continue the movement along the microtubules as they mature into the cis-Golgi.
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Introduction
Vesicles budding from the donor membrane compartment need
to translocate to the target compartment in order to achieve a net
transfer of cargo proteins from one location to another. In the
early secretory pathway, the involvement of microtubules in
vesicular transport processes was evident more than two decades
ago, as cells treated with the microtubule depolymerizing agent
nocodazole had fragmented Golgi [1,2,3]. Manipulating the
expression of certain motor proteins or subunits of the dynactin
complex also disrupt the integrity of the Golgi and other
membrane compartments in the early secretory pathway
[4,5,6,7,8]. The ER exit sites are relatively immobile, so COPII
vesicles are thought to be limited to short-range movement,
although long-range movement has also been observed [9,10]. It
has been demonstrated that COPII vesicles are found at the
growing ends of microtubule tracks, indicating that the COPII
vesicle-microtubule interaction is carried out by a ‘‘search and
capture’’ mechanism, although subsequent studies demonstrated
that this mechanism may not be necessary for COPII vesicle
transport [7,11]. Nonetheless, dynein/dynactin is required for the
movement of vesicles from ER to Golgi [12]. The precise
mechanism of how p150Glued, a subunit of dynactin, directs
COPII vesicle transport remains largely unknown. p150Glued binds
to coat subunits Sec23 and Sec24 at its carboxyl terminal cargo
binding domain, called CTGlued [11]. In cells overexpressing
CTGlued, vesicular transport at the step of ER to Golgi is reduced,
presumably by competitively inhibiting the interaction between
endogenous p150Glued and Sec23/Sec24 at the ER exit sites.
Therefore, p150Glued couples COPII vesicles onto microtubule
tracks to allow the movement of COPII vesicles. p150Glued is
known to stimulate the motor processivity of cytoplasmic dynein
[13], thereby allowing efficient movement of COPII vesicles once
they are associated with microtubules.
p150Glued has been implicated in a number of cellular processes
including the integrity of the Golgi, as depletion of p150Glued by
siRNA results in fragmentation of the Golgi [7,8]. It was thought
that p150Glued depletion causes disruption of microtubule
integrity, which is required for Golgi integrity. The depletion of
p150Glued can cause morphological changes in ER exit sites with a
more diffused staining pattern but does not slow down the rate of
ER to Golgi transport [7]. This particular observation was not
entirely conclusive as the degree of siRNA depletion of p150Glued
was roughly 50%. A more efficient p150Glued depletion may be
required to affect the rate of ER to Golgi transport. We have also
observed that in cells depleted with p150Glued, ER exit sites, shown
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by the marker Sec31A, were dispersed from the perinuclear region
to small puncta (Figure S1). COPI staining, which is enriched in
the ERGIC and cis-Golgi, is also dispersed. These results suggest
that the function of p150Glued on the ER exit sites and/or COPII
vesicle cannot be overlooked but do not provide a clear description
for the role of p150Glued on COPII vesicle transport.
COPII vesicles are tethered by a protein complex called
TRAPP (Transport protein particle) [14,15]. Vesicle tethering
must occur in order to facilitate subsequent docking and fusion
with the target membrane. It has been postulated that TRAPP
recognizes COPII vesicles at the target membrane compartments,
the ERGIC or cis-Golgi, although this interaction may be initiated
at the ER exit sites. TRAPP subunit TRAPPC3 (a.k.a. mBet3) is
enriched in the ER exit sites and can interact with Sec23,
providing the initial interaction between COPII coat and its tether
[16,17].
At least three forms of TRAPP complex with different subunit
composition have been proposed based on biochemical and
genetic studies, and emerging evidence suggests TRAPP com-
plexes could be functionally and structurally more complicated
than initially thought [18,19,20]. In particular, the distinction
between different forms of TRAPP in mammalian system is less
clear [18]. Thus far, it has been firmly established that TRAPP
functions as a COPII vesicle tethering factor and has intrinsic
guanine nucleotide exchange activity toward the small GTPase
Ypt1/Rab1 [14,16,21,22,23].
The intimate relationship between p150Glued and COPII
vesicles is also manifested by their extensive colocalization. We
have observed that approximately 70% of the transfected GFP-
Sec24 signals colocalized with endogenous p150Glued signals in
COS cells (data not shown). The interaction between p150Glued
and Sec23/Sec24 establishes a coupling between vesicle budding
and vesicle movement. The validity of this model relies on whether
Sec23/Sec24 will be released from the vesicle once budding is
completed. Recently, the question has been raised whether
uncoating of COPII vesicle occurs immediately after vesicle
budding [24]. The COPII coat can remain associated with the
vesicle membrane after budding, and partial uncoating is sufficient
to allow vesicle fusion to take place at the target membrane. In this
scenario, Sec23 and Sec24 remain on the vesicle membrane and
can serve as a platform for protein interactions, so that TRAPP
and p150Glued can continue to bind to Sec23 and/or Sec24 to
mediate vesicle tethering and movement, respectively. Vesicle
movement and tethering must also be coordinated so that the
recognition between the vesicle and the target membrane and the
subsequent formation of SNARE pairing can take place without
interference from different vesicle movement speeds. Therefore,
communication between vesicle movement, largely if not solely
mediated by p150Glued, and vesicle tethering, mediated by
TRAPP, must exist. The ERGIC membrane compartments also
move along microtubules as they gradually mature into the cis-
Golgi. As shedding of the COPII coat is an inevitable event after
vesicle fusion, maintaining the movement of tethered and/or fused
vesicles along the microtubule by p150Glued has to rely on an
interaction other than COPII coat proteins. The vesicle tether,
TRAPP, is a prime candidate for such interaction. We investigated
whether dynactin interacts with COPII tethering complex,
TRAPP, and discovered a physical interaction between the
p150Glued and TRAPPC9. This interaction is mediated by the
carboxyl terminal, cargo-binding domain of p150Glued and is
stronger than the p150Glued-Sec23/Sec24 interaction. These
results suggest a new role of COPII tethering factor TRAPP as
a protein complex that helps restrict COPII vesicles on the
microtubules.
Results
TRAPPC9 is localized to the early secretory pathway
In mammals, the TRAPP subunit TRAPPC3 is localized largely
to ER exit sites [17], consistent with its unique function in binding
to COPII coat protein Sec23. Other TRAPP subunits, including
TRAPPC10, TRAPPC2 and TRAPPC4, are largely localized to
the cis-Golgi [23]. TRAPPC9 has been reported to localize to the
ER [25], but our data indicate that TRAPPC9 has limited
localization at the ER exit sites (Figure 1A). More extensive
colocalization was observed between TRAPPC9 and markers for
ERGIC and cis-Golgi, including COPI (Figure 1A), ERGIC-53
and GM130 (Figure 1B). COPI vesicles bud from ERGIC and
carry cargo proteins to the cis-Golgi [26,27]. A more precise
localization study using nocodazole to break up the membrane
compartments into small punctate structures revealed that
TRAPPC9 colocalized extensively with COPI and GM130
(Figure 1C). In cells treated with Brefeldin A (BFA), a majority
of the TRAPPC9 signals became dispersed, suggesting these
signals were associated with the ERGIC or cis-Golgi membranes
(Figure 1D). These membrane structures are BFA-sensitive.
Together, our results and those from others have established that
TRAPP are predominantly localized to the ERGIC and the cis-
Golgi, and to a limited degree, to the ER exit sites.
TRAPP interferes with microtubule architecture
Our initial evidence for the relationship between TRAPP and
microtubules came from the observation that overexpression of
various TRAPP subunits can rearrange microtubule arrays in
COS cells. In normal COS cells, the microtubule tracks radiate
from the MTOC with a star-like astral architecture (Figure 2Aa).
Overexpression of various TRAPP subunits in COS cells can
disrupt the architecture of microtubules in such a way that the
astral appearance becomes disorganized, frequently presenting
as a circular array. One such example is TRAPPC2 overex-
pression (Figure 2Ab, asterisks). This leads to Golgi membrane
fragmentation much like the effect of nocodazole treatment (data
not shown). We further quantified this array interfering effect
induced by TRAPP subunits and found that virtually all TRAPP
subunits tested have this effect at varying degree (Figure 2B).
The varying degree of interference by different TRAPP subunits
is likely a result of the difference in protein expression of these
TRAPP subunits. Large subunits like TRAPPC8, TRAPPC9
and TRAPPC10 are generally expressed at a lower level than
the smaller subunits, and therefore, had lower percentage of cells
showing circular arrays (Figure 2B). GFP-tagged TRAPP
subunits acted similarly (Figure S2), suggesting the effect is
independent of the tag. The extent of interference is similar to
that observed for overexpression of a subunit of the dynactin
complex, p50 (Figure S2, second bar) [28]. This effect is specific
as myc-tagged Sec13, a COPII coat subunit, showed little, if
any, effect on microtubule arrangement (Figure 2Aa, asterisks).
We confirmed that the MTOC remains intact in cells
overexpressing various TRAPP subunits as indicated by the
presence of an intense single focus of c-tubulin signal juxtaposed
by the nucleus (Figure 2C, arrowheads). These results indicate
that an interaction between TRAPP and a microtubule-
associated protein must exist. The overexpression of TRAPP
subunits does not affect the MTOC, but must compete away the
microtubule-associated protein from its native location on the
microtubule. This upsets the proper interaction between TRAPP
and the microtubule, resulting in abnormal microtubule
arrangement.
TRAPPC9 Binds to p150Glued
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TRAPPC9 interacts with p150Glued
p150Glued is known to interact with COPII coat proteins Sec23
and Sec24, and TRAPP subunit TRAPPC3 mediates the tethering
of COPII vesicles by binding to Sec23. Therefore, we hypothe-
sized that p150Glued could be the microtubule-associated protein
that is affected by TRAPP subunit overexpression. We tested
whether p150Glued interacts with TRAPP by a co-immunoprecip-
itation experiment. In COS cells overexpressing various Myc-
tagged TRAPP subunits together with FLAG-tagged p150Glued,
we immunoprecipitated the Myc-tagged TRAPP subunits and
detected whether FLAG-p150Glued is present in the pull-downs.
TRAPPC2 and TRAPPC9 were observed to interact with
p150Glued most strongly (Figure 3A, lanes 3 and 6). To a lesser
degree, other TRAPP subunits were also able to interact with
p150Glued. However, the interaction between TRAPPC9 and
p150Glued is the most consistent in our experience. It is likely that
the interaction between p150Glued and other TRAPP subunits
could be a result of indirect interaction via endogenous TRAPPC9
in the precipitation. To confirm that the TRAPP complex indeed
interacts with p150Glued in vivo, we determined whether
endogenous p150Glued is associated with endogenous TRAPP
complex isolated from HEK293 lysate by immunoprecipitation
using an antibody specific to TRAPPC9. As shown in Figure 3B,
immunoprecipitant from anti-TRAPPC9 antibody (Figure 3B,
lane3), but not control anti-LAMP2 antibody (Figure 3B, lane 2)
was able to co-precipitate p150Glued and TRAPPC10, another
TRAPP subunit. As a control, peripheral Golgi protein Golgin-97
was not present in either immunoprecipitant (Figure 3B, bottom
panel). Similar co-IP experiments using lysates from Caco-2 and
CHO cells also detected interaction between p150Glued and
TRAPPC9 (data not shown). Together, we have confirmed that a
physical interaction between TRAPP complex and p150Glued
exists in vivo and this interaction is most likely mediated by
TRAPPC9.
We further investigated which domain of p150Glued interacts
with TRAPPC9. The interaction between Sec23/Sec24 and
p150Glued is mediated by the cargo-binding domain at the
carboxyl terminus of p150Glued, called CTGlued (Figure 4A). As
Figure 1. TRAPPC9 is predominantly enriched in cis-Golgi and ERGIC. CHO cells were stained with TRAPPC9 and various markers by indirect
immunofluorescence. TRAPPC9 were detected by affinity purified rabbit IgG specific to TRAPPC9, followed by Alexa Fluor 568- conjugated goat anti
rabbit secondary antibody. Organelle markers are detected by mouse monoclonal antibodies against the indicated proteins, followed by Alexa Fluor
488 conjugated goat anti- mouse secondary antibody. The extent of colocalization is presented in the merge images. The boxed areas are enlarged as
insets. (A). TRAPPC9 (red) extensively colocalizes with COPI (green), which is enriched in the ERGIC and cis Golgi, and partially with transfected GFP-
Sec31. (B). TRAPPC9 also extensively colocalizes with cis Golgi marker, GM130, and partially with ERGIC (ERGIC-53). (C). CHO cells treated with
nocodazole for 1 h before fixed and stained with indicated antibodies. Small puncta derived from the dispersal of the Golgi membranes showed
extensive overlap of TRAPPC9 signal (red) with GM130 (green, top panels) and COPI (green, bottom panels). (D). CHO cells treated with or without
10 mg/ml BFA for 1 hours before staining with antibodies against TRAPPC9 (top panels) or COPI (bottom panels). Scale bar = 20 mm.
doi:10.1371/journal.pone.0029995.g001
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shown in Figure 4B, CTGlued binds to TRAPPC9 most strongly
and consistently (lane 6). Weak and less consistent interactions
were also detected with other TRAPP subunits, e.g. TRAPPC10
(Figure 4B, lane 7). The amino-terminal of p150Glued, NTGlued, did
not bind to any TRAPP subunits tested (Figure 4C). Therefore,
TRAPPC9 interacts with the cargo-binding domain of p150Glued,
similar to Sec23 and Sec24.
As overexpressing TRAPP subunits affects microtubule archi-
tecture without affecting the integrity of the MTOC, we
hypothesized this effect could be due to a mislocalization of
p150Glued in TRAPP-overexpressing cells. In COS cells, p150Glued
is diffuse in the cytosol, at the microtubule plus ends at the cell
periphery and at the MTOC (Figure 5, arrowheads). Overex-
pressing the indicated TRAPP subunits disrupted p150Glued
localization at the MTOC (Figure 5, asterisks), suggesting that
the interfering effect on microtubule architecture by TRAPP
overexpression is caused by mislocalization of endogenous
p150Glued in the TRAPP-transfected cells.
p150Glued can be found in the cytosol and in the perinuclear
region that includes the MTOC (Figure S3). When the cells were
fixed with formaldehyde, a more diffuse cytosolic staining pattern
with stronger signals around the perinuclear region was observed.
Some of the p150Glued perinuclear signals colocalize with
TRAPPC9 (Figure S3A). These signals are different from the
intense and dot-like structure found at the MTOC in methanol
fixed cells (Figure 5). In cells treated with nocodazole, p150Glued
localization is dispersed into small punctate structures due to the
absence of intact microtubules. Some of the p150Glued-positive
punctate structures clearly colocalize with the TRAPPC9 puncta
(Figure S3B). Higher magnification revealed that p150Glued is
closely associated with the TRAPPC9-positive puncta (Figure
S3C, arrows). These results are consistent with a close association
between p150Glued and TRAPPC9 in vivo.
TRAPPC9 competes with Sec23/Sec24 for p150Glued
binding
What is the functional relationship between TRAPPC9,
p150Glued and Sec23/Sec24? We performed co-immunoprecipi-
tation to test if the presence of TRAPPC9 could interfere with the
interaction between p150Glued and Sec23/Sec24. In this experi-
ment, Myc-tagged Sec23 or Sec24 was co-transfected with FLAG-
tagged CTGlued. The effect of TRAPPC9 on p150Glued-Sec23/
Sec24 interaction was assessed by co-transfection of GFP-
TRAPPC9. The transfection conditions were carefully determined
to achieve a comparable level of expression for each protein
(Figure 6A, bottom three panels). The presence of TRAPPC9
strongly inhibited the abilities of Myc-Sec23 or Myc-Sec24 to pull-
down FLAG-CTGlued (Figure 6A, top panel, compare lanes 2 and
3 with lanes 5 and 6, respectively), suggesting that interactions
between CTGlued and Sec23 or Sec24 were inhibited by
TRAPPC9. Furthermore, TRAPPC9 was better able to pull
down CTGlued than Sec23 or Sec24, suggesting a stronger
interaction (Figure 6A, top panel, compare lanes 2 and 3 with
lane 4). In a similar experiment, we immunoprecipitated FLAG-
p150Glued and determined how Sec23 and Sec24 compete with
TRAPPC9 for p150Glued. As shown in Figure 6B, neither the co-
transfected YFP-Sec23 nor GFP-Sec24C was able to compete with
GFP-TRAPPC9 for the interaction of FLAG-p150Glued (Figure 6B,
top panel). Taken together, this experiment demonstrates that
TRAPPC9 inhibits the interaction between p150Glued and Sec23/
Sec24, most likely by competitive binding to the cargo-binding
domain, CTGlued.
If TRAPPC9 competes with Sec23/Sec24 for the binding with
p150Glued, one will expect the overexpression of TRAPPC9 can
reduce the association of p150Glued and ER exit sites. We tested
this hypothesis by overexpressing TRAPPC9 in COS cells and
Figure 2. Overexpression of TRAPP subunits disrupts the microtubule ‘‘star-like’’ astral architecture in COS cells. (A) COS cells
overexpressing the indicated Myc-tagged proteins are shown in the lower panels and the same cells are marked by red asterisks in the upper panels.
Myc-tagged proteins were stained with Rhodamine-conjugated mouse anti-Myc antibody. Microtubules were stained with mouse antibody against b-
tubulin, followed by Alexa Fluor 488 conjugated goat anti mouse secondary antibody. (B) Quantification of the status of microtubule architectures in
COS cells overexpressing various TRAPP subunits. In all samples, at least 100 cells were counted. (C) TRAPP overexpression did not disrupt the MTOC.
COS cells transfected with the indicated TRAPP subunits were stained with MTOC marker c-tubulin (red). The integrity of the MTOC can be visualized
by a single intense fluorescent dot (arrows). Scale bar = 20 mm (A); = 10 mm (C).
doi:10.1371/journal.pone.0029995.g002
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determined whether the extent of colocalization between
p150Glued and COPII coat components was reduced. In this
experiment, we treated the transfected cells with nocodazole
before fixation and staining, so that the signals of p150Glued and
Sec23 around the MTOC became dispersed, and the extent of
colocalization can be quantified more easily by the number of
colocalized fluorescence dots. COS cells were used because their
flat morphology allows easy quantification of the fluorescence
signals, despite the presence of non-specific nuclear signal labeled
by the Sec23 antibody. The result indicated that TRAPPC9
disrupts the colocalization between ER exit sites and p150Glued. In
cells overexpressing GFP-TRAPPC9 (Figure 7B–D), the extent of
colocalization between p150Glued and ER exit sites decreased from
7.72% non-transfected cells to 3.83% in GFP-TRAPPC9
transfected cells (Figure 7D). In a similar experiment, overex-
pressing Myc-TRAPPC9 also disrupted the colocalization between
p150Glued and ER exit sites. The extent of p150Glued and ER exit
sites colocalization decreased from 7.27% in non-transfected cells
to 3.56% in Myc-TRAPPC9 transfected cells (Figure 7E). To
further illustrate the effect of TRAPPC9 on disrupting the
interaction between p150Glued and ER exit sites, we co-transfected
GFP-Sec24C and Myc-TRAPPC9 in Hela cells and determined if
the colocalized signals between GFP-Sec24C and endogenous
p150Glued were reduced (Figure 7F). In cells co-transfected with
GFP-Sec24C and Myc-vector, approximately 32% of the GFP-
Seec24C fluorescence dots were colocalized with endogenous
p150Glued signals, as compared to approximately 7% of endoge-
nous Sec23A signals colocalized with endogenous p150Glued shown
in Figure 7D. The reason for this increase is currently not clear but
we have excluded the possibility that GFP-Sec24C overexpression
could drive its interaction with p150Glued because we observed a
similar increase of colocalized signals between p150Glued and ER
exit sites by overexpressing GFP-Sec31A (data not shown). Co-
transfection with Myc-TRAPPC9 decreased the p150Glued-GFP-
Sec24C colocalized signals from 32% to 18%. As a positive
control, we co-transfected Myc-CTGlued with GFP-Sec24C.
CTGlued interacts with Sec23/Sec24 and TRAPPC9. Overexpres-
sion of CTGlued disrupted the interaction between p150Glued and
ER exit sites and reduced the p150Glued-GFP-Sec24C colocalized
signals to 23%. Sar1b did not cause any change in microtubule
architecture and has not been reported to affect dynactin function.
Therefore, we co-transfected Myc-Sar1b as a negative control. Co-
transfection with Myc-Sar1b did not reduce the colocalization
between GFP-Sec24C and p150Glued as demonstrated by Myc-
TRAPPC9 and Myc-CTGlued. In fact, Sar1b caused a slight
increase in colocalization between GFP-Sec24C and p150Glued.
We do not know the precise cause for this so far. Nonetheless, the
result in Figure 7F is in agreement with Figure 7D and 7E,
confirming the inhibitory effect of TRAPPC9 on the interaction
between p150Glued and ER exit sites. If the overexpression of
TRAPPC9 is able to reduce the colocalization between p150Glued
with ER exit sites, one will expect depleting TRAPPC9 can
increase such colocalization. In HEK293 cells depleted with
TRAPPC9 by siRNA, we observed the colocalized signals between
p150Glued and GFP-Sec24C increased from 33.15% to 48.74%
(Figure 7G). Therefore, TRAPPC9 overexpression could inhibit
the interaction between COPII vesicles and p150Glued in vivo and
its depletion could increase the association between p150Glued and
COPII vesicles.
Discussion
A close relationship between TRAPP and microtubules is
evident from the previous report that the localization of
TRAPPC3 is resistant to the treatment of brefeldin A but is
disrupted by nocodazole [17]. Furthermore, the restoration of
TRAPPC3 localization after removal of nocodazole can be
achieved even in the presence of brefeldin A (data not shown),
suggesting that proper localization of TRAPPC3 is predominantly
dependent on microtubule integrity rather than membrane
compartment integrity in the early secretory pathway. The
depletion of TRAPPC3, however, did not cause major changes
to microtubule architecture [17]. These observations are consis-
tent with the hypothesis that TRAPP does not actively affect
microtubule and motor function directly but relays the movement
Figure 3. p150Glued interacts with TRAPP. (A) The indicated myc-
tagged TRAPP subunits were overexpressed with FLAG-tagged
p150Glued in COS cells. Co-immunoprecipitations were performed using
antibody against c-Myc. The presence of FLAG-p150Glued in the pull-
down is detected by immunoblotting with antibody against FLAG (top
panel). The extent of Myc-tagged TRAPP subunits precipitated was
determined in immunoblotting using antibody against c-Myc (middle
and bottom panels). Approximately 1% of the input lysates and 25% of
the immunoprecipitants were loaded. (B) HEK293 cell lysates were
subjected to immunoprecipitation using antibody specific to TRAPPC9
or to LAMP2 (negative control). The presence of TRAPPC9 (top panel),
p150Glued (second panel), and TRAPPC10 (third panel) in the immuno-
precipitants were detected by immunoblotting using antibodies
specific to these proteins. As negative control, Golgin-97 was not
detected in the immunoprecipitants (bottom panel). For TRAPPC9,
TRAPPC10 and Golgin-97, approximately 0.5% of the input lysates and
17% of the immunoprecipitants were loaded. For p150Glued, approxi-
mately 0.1% of the input lysates and 30% of the immunoprecipitants
were loaded.
doi:10.1371/journal.pone.0029995.g003
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of cargo via an exchange of interaction from COPII coat and
dynactin to COPII tether and dynactin. However, ectopic
overexpression of TRAPP can compete p150Glued away from its
native location, thus indirectly affecting the integrity of microtu-
bule architecture.
Here, we started with the observation that TRAPP is
functionally linked to the microtubules, and then identified that
p150Glued, a subunit of dynactin, interacted with TRAPP via the
subunit TRAPPC9. This novel interaction between p150Glued and
TRAPP adds a new perspective to the function of TRAPP. Vesicle
tethering at the target membrane is viewed as the end point of a
trafficking step. Here, our data suggest that tethering of COPII
vesicles by TRAPP at the ERGIC may serve as a starting point for
the movement of the tethered and/or fused vesicles, i.e., the
nascent ERGIC, toward the cis-Golgi, with TRAPP now serving
as an adaptor between the ERGIC and dynactin (Figure 8). In this
model, when a COPII vesicle approaches the ERGIC (or another
COPII vesicle in the case of homotypic vesicle tethering), a fully
assembled TRAPP complex, which includes TRAPPC9, will
activate Rab1 and serve as a tether for the COPII vesicle. At that
point, TRAPPC9 will compete for the interaction of p150Glued
thereby shedding the Sec23/Sec24 dimer, thus relaying the
interaction between vesicle and p150Glued, and at the same time,
preparing the vesicle for docking and fusion. Preservation of the
vesicle-dynactin interaction for the subsequent movement of
ERGIC is a key feature of this model. It has been well documented
that the ERGIC moves toward the cis-Golgi as the organelle
gradually matures.
Thus far, it is not clear the extent to which COPII coat subunits
are released from the budded COPII vesicle in vivo. It is possible
that only partial uncoating is required for COPII vesicles to fuse
with the target membrane [24]. In yeast, COPII vesicles remain
coated until they reach the Golgi, where casein kinase I d/Hrr25p
phorsphorylates Sec23p to promote uncoating of the vesicles [29].
Figure 4. TRAPPC9 interacts with CTGlued. (A) Schematic diagram of p150Glued structure. NTGlued and CTGlued were subjected to co-
immunoprecipitation experiments. FLAG-tagged CTGlued (B) and FLAG-tagged NTGlued (C) were co-transfected with various Myc-tagged TRAPP
subunits for immunoprecipitation. The extent of Myc-TRAPP subunit precipitation was determined by immunoblotting with anti-Myc antibody
(middle panels). The presence of co-precipitated FLAG-CTGlued or FLAG-NTGlued was determined by anti-FLAG antibody (top panels). The level of
protein expression in input lysates was determined by anti-FLAG or anti-Myc antibody (bottom panels). The precipitated anti-Myc IgG light chain was
marked as asterisk in the immunoprecipitation samples. Approximately 1% of the input lysates and 25% of the immunoprecipitants were loaded.
doi:10.1371/journal.pone.0029995.g004
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This finding suggests the uncoating of COPII vesicles at the target
membrane happens concomitantly with other biochemical events
such as vesicle tethering and fusion, and COPII coat components
could be present at the target membrane. Indeed, it has previously
been reported that Sec13-positive signals significantly overlap with
ERGIC-53 [26,30], suggesting remnant COPII coat can stay on
the membrane even after COPII vesicle fusion. The remaining
COPII coat may serve as a platform for protein interactions,
permitting the binding of p150Glued for vesicle movement and/or
of TRAPP for tethering of other incoming vesicles. The
TRAPPC9-p150Glued may, in turns, indirectly promote shedding
of Sec23 and Sec24 from the fused vesicles so that these
membrane compartments will gradually assume the identity of
the cis-Golgi.
The localization of TRAPPC9 at the target membrane, e.g. the
ERGIC, will determine the precise timing of the dissociation of
p150Glued from Sec23/Sec24. Evidence suggesting TRAPPC9 is
localized to the ERGIC also comes from cells transfected with a
constitutively active form of Sar1, Sar1[H79G]. In Sar1[H79G]
transfected cells, COPII coat proteins become concentrated
around the MTOC due to impaired uncoating [31,32]. Similar
to the pattern of GFP-Sec24C, p150Glued signal clustered at the
MTOC in cells transfected with Sar1[H79G], suggesting that
binding of p150Glued to Sec23/Sec24 can occur before uncoating
(Figure S4A, left panels). The TRAPPC9 signal becomes diffuse
and cytosolic in this condition (Figure S4A, right panels). As a
control, wildtype Sar1 did not cluster TRAPPC9 or GFP-Sec24C
(Figure 4B). These data suggest that there is a fundamental
difference in the way p150Glued and TRAPPC9 interacts with
COPII vesicles in that p150Glued can bind to fully coated COPII
vesicles but TRAPPC9 cannot ‘‘see’’ such fully coated vesicles to
be clustered at the MTOC. This is different from the localization
of TRAPPC3, which clusters at the MTOC like p150Glued in
Sar1[H79G] transfected cells (data not shown). Therefore it is
likely that TRAPPC9 can only come into contact with COPII
vesicle during uncoating, at which time it competes with Sec23/
Sec24 for the interaction with p150Glued, and the only logical site
for such event to take place is at the target membrane, the
ERGIC. We speculate that the dissociation between Sec23 and
Sec24 may be necessary to weaken the tripartite interaction
sufficiently so that TRAPPC9 can successfully displace Sec23 and
Sec24 for p150Glued. These results are consistent with our
hypothesis that p150Glued binds to COPII coat initially to conduct
vesicle movement, and then TRAPP-mediated tethering of the
vesicle at the target membrane will preserve the p150Glued-
mediated movement of the tether and/or fused vesicles towards
the cis-Golgi.
Two of the best-characterized biochemical functions of TRAPP
are COPII vesicle binding via TRAPPC3 and Sec23 interaction,
and GEF activity of Rab1/Ypt1p. In mammals, Sec23 is enriched
in ER exit sites and Rab1 is enriched in ERGIC [33].
Paradoxically, both of these membrane compartments are
different from the predominant localization of the TRAPP
subunits at the cis-Golgi. We speculate here that the assembly of
the TRAPP complex in vivo may be sequential, initiated by the
binding of TRAPPC3 to Sec23 at the ER exit sites, and the
complex is fully assembled at the ERGIC and remains on the
membrane at steady state as the ERGIC matures into the cis-
Golgi. The different behaviors of TRAPPC3 and TRAPPC9 with
Sar1[H79G] overexpression seems to be in agreement with this
notion. Indeed, sequential assembly of TRAPP complex via the
conversion of TRAPPI to TRAPPII through the addition of the
TRAPPII-specific subunits has been implicated in yeast [34].
Unlike TRAPPC3, the localization of TRAPPC9, as well as other
TRAPP subunits, is sensitive to BFA, suggesting a dependence on
Golgi membrane integrity. Therefore, even if TRAPP complex
assembly is initiated on COPII vesicles, anchoring of TRAPP to
the cis-Golgi must be mediated by yet another mechanism.
Materials and Methods
DNA and siRNA
cDNAs encoding mammalian TRAPP subunits were amplified
by PCR and subcloned into pCMV-Myc (Clontech) or peGFP-Cx
vector (Clontech). Myc-sec23A and Myc-sec24D were constructed
by transferring the corresponding cDNA sequences into pCMV-
Myc [16]. cDNA encoding human P150Glued was purchased from
Open Biosystem and transferred from vector pYx-Asc to pFLAG-
CMV2 (Sigma). The carboxyl terminus of p150Glued (amino acid
938–1254, CTGlued) was amplified from plasmid p150Glued by
PCR and subcloned into pFLAG-CMV2 and pCMV-Myc. siRNA
Figure 5. Overexpression of TRAPP subunits disrupts the MTOC localization of endogenous p150Glued. COS cells transfected with the
indicated GFP tagged TRAPP subunits (bottom panels) were stained with endogenous p150Glued. The presence of p150Glued signal at the MTOC can
be observed in the non-transfected cells (Arrowheads). In cells transfected with the indicated TRAPP subunits, (asterisks, top panels), the signal of
p150Glued at the MTOC disappeared. Scale bar = 20 mm.
doi:10.1371/journal.pone.0029995.g005
TRAPPC9 Binds to p150Glued
PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e29995
targeting to human p150Glued: 59-gacuucaccccuugauuaauu-39 was
designed according to Dixit et al [8]. siRNAs targeting to
TRAPPC9 were designed using the algorithm designed by
Invitrogen: The sequences of the oligoes are as follows: 1) 59-
gcugcugcguucugugaauuu; 2) 59- gcauggaagcaucagaauuuu; 3) 59-
gcaacaaagcaggcgacuauu.
Figure 6. TRAPPC9 competes with Sec23 and Sec24 for binding to p150Glued. (A) Myc-Sec23 (lanes 2 and 5) or -Sec24 (lanes 3 and 6) were
co-transfected FLAG-CTGlued for co-immunoprecipitation experiments. The ability of TRAPPC9 to inhibit the interaction between Sec23 or Sec24 with
CTGlued was determined by the presence of GFP-TRAPPC9 (lanes 5–6). The amount of FLAG-CTGlued co-precipitated was determined by
immunoblotting with anti-FLAG antibody (top panel). The amount of Myc-tagged protein precipitated was determined by blotting with anti-Myc
antibody (second panel). Levels of protein expression in the transfected cell lysates were determined by blotting the input lysates with the indicated
antibodies (bottom three panels). (B) Transfected Sec23 or Sec24 lost the ability to bind to p150Glued in the presence of co-transfected TRAPPC9.
Transfected FLAG-p150Glued was precipitated by antibody against FLAG (second panel). The presence of co-precipitated YFP-Sec23A, GFP-Sec24C or
GFP-TRAPPC9 was detected by antibody against GFP (top panel). Only TRAPPC9, but not Sec23 or Sec24, could be co-precipitated with FLAG-
p150Glued. The levels of protein expression in the transfected cell lysates were determined by blotting the input lysates with the indicated antibodies
(bottom two panels). In both experiments shown in (A) and (B), approximately 1% of input lysates and 25% of the immunoprecipitants were loaded.
doi:10.1371/journal.pone.0029995.g006
TRAPPC9 Binds to p150Glued
PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29995
Antibodies
Mouse monoclonal antibodies against c-Myc, 9E10 (sc-40),
9E10-conjugated with TRITC, and rabbit polyclonal antibody
against GFP (sc-8334) were purchased from Santa Cruz
Biotechnology, Inc. (CA, USA). Monoclonal antibody against
Golgin-97, was a gift from Dr. Wing Keung Liu’s laboratory (The
Chinese University of Hong Kong), and was originally purchased
from Invitrogen. Monoclonal antibody against Sec31A (612350),
GM130 (610823) and p150Glued (610474) were purchased from
BD Biosciences. Monoclonal antibody against ERGIC-53 was
obtained from Hans-Peter Hauri (University of Basel, Switzerland)
[35]. Mouse monoclonal antibody against TRAPPC10, 5B4
(H00007109-M01) was purchased from Abnova corporation.
Mouse monoclonal antibody against b-tubulin, TUB 2.1
(T4026), against c-tubulin (T6557), against FLAG (Clone M2)
was purchased from Sigma. Rabbit polyclonal antibody against
LAMP2 was purchased from Alexis (210-206-R100). Alexa Fluor
secondary antibodies were purchased from Invitrogen: 488 goat
anti-mouse (A11017), 568 goat anti-mouse (A11019), 635 goat
anti-mouse (31575), 488 goat anti-rabbit (A11070) and 568 goat
anti-rabbit (A21069). Horseradish Peroxidase Conjugated second-
ary antibodies were purchased from Rockland: anti-mouse IgG
Figure 7. Overexpression of TRAPPC9 reduces the association of p150Glued and ER exit sites in vivo. Non-transfected (A) or GFP-
TRAPPC9-transfected (B) COS cells, were treated with nocodazole before staining with p150Glued and Sec23A. p150Glued signal was scanned by
confocal microscopy at 633 nm and pseudo-colored in green. Sec23A was scanned at 543 nm and visualized in red; GFP-TRAPPC9 signal was scanned
at 488 nm and visualized in white. Scale bar = 20 mm. The boxed areas are enlarged and presented in (C). Fluorescent dots of p150Glued and Sec23A
that are colocalized are indicated by arrows. Scale bar = 5 mm. (D) Quantifications of the colocalized signals in (C) as percentages of Sec23A-positive
fluorescent dots that colocalized with p150Glued-positive dots. In non-transfected cells, 7.72% (S.E.M. = 0.648%) of the Sec23A dots were found to
colocalize with p150Glued. A total of 890 Sec23A fluorescent dots in 8 cells were counted. In GFP-TRAPPC9 transfected cells, 3.83% (S.E.M. = 0.577%)
Sec23A dots colocalized with p150Glued. 493 dots in 7 cells were analyzed. (E) Myc-TRAPPC9, instead of GFP-TRAPPC9, was transfected into COS cells.
Sec23A was labeled with AF488-conjugated secondary antibody, p150Glued was labeled with AF633-conjugated secondary antibody, and Myc-
TRAPPC9 was labeled with TRITC-conjugated mouse anti-Myc antibody. In 11 non-transfected cells analyzed, a total of 1571 Sec23A-positive dots
were analyzed and 7.27% (S.E.M. = 0.313%) colocalized with p150Glued-positive dots. In comparison, 3.56% (S.E.M. = 0.665%) colocalization was
observed in Myc-TRAPPC9 transfected cells. 1087 Sec23A-positive dots in 10 transfected cells were analyzed. (F) Hela cells co-transfected with GFP-
Sec24C and the indicated sequences in Myc-tagged vector. Endogenous p150Glued was labeled with AF633-conjugated secondary antibody and the
overexpressed Myc-tagged proteins were labeled with rhodamine-conjugated mouse anti-c-Myc IgG. Colocalized signals between p150Glued and
GFP-Sec24C were counted as above. Fluorescence signals from at least six cells were counted, with totally 262 dots or more for each sample. (G)
HEK293 cells were transfected with Luciferase siRNA or three combined TRAPPC9 siRNAs for 72 hrs. Three TRAPPC9-specific siRNAs efficiently
depleted the target protein as shown by immunoblotting (top panels). TRAPPC9 depletion significantly increased the co-localization of GFP-Sec24C
and p150Glued from 33.15% (S.E.M. = 0.369%) to 48.74% (S.E.M. = 0.22%). In this experiment, 473 fluorescent dots in 10 cells (control luciferase
knockdown), and 494 dots in 11 cells (TRAPPC9 knockdown) were analyzed. Error bars = S.E.M.
doi:10.1371/journal.pone.0029995.g007
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(610–1302) and anti-rabbit IgG (211–1302). Rabbit polyclonal
antibody against TRAPPC9 was raised to a GST fusion protein
that contained amino acids 840–1143 of human TRAPPC9 [36].
Cell culture and transfection
COS1, HEK293, Hela cells are maintained in Dulbecco’s
minimum essential medium (DMEM) (Invitrogen) supplemented
with 10% fetal bovine serum (FBS) (Invitrogen). Chinese hamster
ovary CHO-K1 cells were grown in DMEM supplemented
0.35 mM L-proline (Sigma), 10% FBS. All four cell lines were
obtained from the ATCC (Manassas, VA). Transfection assay was
performed with polyethylenimine (PEI) method (Godbey et al.,
1999) or PolyJet (SL100688) according to the manufacturer’s
instructions (SignaGene Lab). 24–36 hours after transfection, the
cells were harvested for analysis.
Immunoprecipitation
Transfected COS1 cells in 10 cm tissue culture plates were lysed
in lysis buffer (20 mM Tris, pH 8.0, 100 mM NaCl, 0.1% NP-40
and 16 protease inhibitor cocktail CompleteH (Roche)). The cells
were scraped down and collected in 1.5 ml tubes. After brief
vortex, the lysates were centrifuged at 10,000 rpm at 4uC for
10 minutes. The supernatants were subject to immunoprecipita-
tion with 1–2 mg of anti-Myc or anti-FLAG antibody and 30 ml of
protein-A sepharose slurry (sigma, P3391). After at least 3 hours of
incubation at 4uC with agitation, the immunoprecipitants were
washed three times with lysis buffer and once with 20 mM Tris,
pH 8.0 and 100 mM NaCl. 35 ml of 26SDS sample buffer were
added to each immunoprecipitant and the samples were subjected
to SDS-PAGE and immunoblotting analysis. For native immuno-
precipitation with anti-TRAPPC9 antibody, lysates generated
from approximately 26107 HEK293 cells were subjected to
immunoprecipitation using antibody against TRAPPC9, or
against LAMP2 (negative control). The rest of the procedures
are identical to description mentioned above.
Fluorescence microscopy
Cells grown on 12-mm coverslips were fixed in PBS with 3.7%
formaldehyde for 15 min, quenched with 1% BSA in PBS,
permeabilized with 0.1% Triton X-100 in PBS and blocked in
PBS plus 1% BSA for the staining using anti-TRAPPC9 antibody.
Others were fixed in cold methanol for 5 min and re-hydrated
with 1%BSA in PBS for 20 min. The samples were incubated with
primary antibodies at room temperature for 30 min, washed with
1% BSA in PBS three times, incubated with secondary antibodies
for 30 min and then mounted on glass slide in Fluoromount-G
(Southern BioTech, USA, 0100-01). Specific Alexa Fluor conju-
gated goat anti-mouse or goat anti-rabbit secondary antibodies are
described in the figure legends. For colocalization of p150Glued and
GFP-Sec24C, after secondary antibody incubation cells needed
second fixation with 3.7% formaldehyde and staining with
antibody against c-Myc conjugated rhodamine [c-Myc (9E10)
TRITC]. Image of stained cells were acquired with Carl Zeiss
LSM-5 or Olympus FV1000 laser scanning confocal microscope
equipped with 636objective lens. The images were processed with
Adobe Photoshop 7.0.
For immunofluorescence colocalization studies shown in
Figure 7, the transfected COS, Hela or HEK293 cells were
treated with 10 mg/ml Nocodazole for 60 minutes before staining.
The degree of colocalization was calculated as a percentage of
COPII fluorescent dots (presented by endogenous Sec23A or
transfected GFP-Sec24C) that were also overlapped with
p150Glued fluorescence dots. Substantial amount of p150Glued
signal is diffused and cytosolic, and COPII dots overlapping with
the diffused p150Glued signals were excluded from our counting.
Statistics analysis was done by student’s two-sample T-test.
Figure 8. Schematic diagram depicting how TRAPP and p150Glued coordinate the movement and tethering of a COPII vesicle is
tethered at the ERGIC. (1). Dyneine-powered movement of a fully coated COPII vesicle along microtubule is mediated by an interaction between
p150Glued and Sec23/Sec24. (2). TRAPP subunits assemble onto the vesicle to form a fully functional TRAPP complex during the movement. (3). When
the vesicle reaches the ERGIC, COPII coat will be partially shed to facilitate vesicle fusion but the interaction between p150Glued and the vesicle is now
mediated by the TRAPPC9-p150Glued interaction. (4). TRAPP is anchored on the target membrane by a currently unknown mechanism. (5). The vesicle
may fuse with the ERGIC but the TRAPPC9-p150Glued interaction continues to help move the ERGIC towards the cis-Golgi.
doi:10.1371/journal.pone.0029995.g008
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Supporting Information
Figure S1 Depletion of p150Glued disrupts the integrity
of the ER exit sites. (A). HEK293 cells were depleted with
p150Glued by siRNA. The extent of depletion was monitored by
immunoblotting. (B). ER exit sites (Sec31A), trans-Golgi (Golgin-
97) and ERGIC & cis-Golgi (COPI) were dispersed in p150Glued
depleted cells. siRNA specific to luciferase was used as control
depletion. Scale bar = 20 mm.
(TIF)
Figure S2 Overexpression of GFP-tagged TRAPP sub-
units disrupts the star-like astral microtubule architec-
ture in COS cells. In each data points, at least 100 transfected
cells were counted.
(TIF)
Figure S3 TRAPPC9 partially colocalizes with
p150Glued. CHO cells were stained with TRAPPC9 (red) and
p150Glued (green). (A). p150Glued signal is present in cytosol but the
typical p150Glued pattern of short stretch of fiber near the cell
periphery is not as obvious in formaldehyde-fixed cells (see
Materials and Methods). The p150Glued signal in the MTOC is
masked by the nearby and equally intense signal that overlaps with
TRAPPC9. A significant portion of the p150Glued signal is present in
the cis-Golgi. (B). In nocodazole-treated cells, both TRAPPC9 and
p150Glued signals were dispersed into small puncta. (C) Magnified
images of the puncta show close association between TRAPPC9
and p150Glued (arrows). Scale bar= 20 mm (A and B); =
5 mm (C).
(TIF)
Figure S4 Overexpression of Sar1[H79G] clusters
p150Glued signals at the MTOC but disperses the Golgi-
localized signals of TRAPPC9. (A). CHO cells transfected
with DNA plasmids for Myc-Sar1[H79G] and GFP-Sec24C at
molar ratio 5:1. At this ratio, essentially all the cells expressing
GFP-Sec24C were also positive for Sar1[H79G] expression. The
cells were stained with p150Glued (left panels) or TRAPPC9 (right
panels). The clustering of ER exit sites at the MTOC due to the
effect of Sar1[H79G] is determined by the fluorescence pattern of
GFP-Sec24C (bottom panels). Cells expressing GFP-Sec24C, and
hence, Sar1[H79G], are marked with red asterisks in the top
panels. (B). CHO cells were transfected with wildtype Sar1 instead.
Other conditions are identical to those described in (A). Scale
bar = 20 mm.
(TIF)
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